TimesSquare Capital Management’s Endologix Inc ELGX Stock Holding History

TimesSquare Capital Management’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-381,467	Closed	-$27.6M	–	271
2017 Q1	$27.6M	Buy	381,467 +37,188	+11%	+$2.46M	0.18%	196
2016 Q4	$19.7M	Buy	344,279 +4,800	+1%	+$440K	0.13%	210
2016 Q3	$43.5M	Buy	339,479 +25,865	+8%	+$3.31M	0.28%	139
2016 Q2	$39.1M	Buy	313,614 +48,900	+18%	+$5.62M	0.26%	148
2016 Q1	$22.1M	Sell	264,714 -1,046	-0.4%	-$86.2K	0.14%	200
2015 Q4	$26.3M	Buy	265,760 +38,260	+17%	+$4.1M	0.17%	182
2015 Q3	$27.9M	Buy	+227,500	New	+$30.9M	0.18%	186

Other funds holding ELGX

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

TimesSquare Capital Management's ELGX Position: Q2 2017 in Review

TimesSquare Capital Management sold out of Endologix Inc (ELGX) in Q2 2017, closing a stake of 381,467 shares — an estimated $27.6M sold.

TimesSquare Capital Management first reported a position in ELGX in Q3 2015 and held it in 7 quarters. The position peaked at $43.5M in Q3 2016. 111 funds tracked by Wall St. Rank hold ELGX as of Q2 2017.

TimesSquare Capital Management reported no remaining Endologix Inc position as of Q2 2017 after selling out during the quarter.
TimesSquare Capital Management sold 381,467 Endologix Inc shares in Q2 2017, an estimated $27.6M.
TimesSquare Capital Management first reported a position in Endologix Inc in Q3 2015 and held it in 7 quarters.
TimesSquare Capital Management's Endologix Inc position peaked at $43.5M in Q3 2016.
111 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2017.

Based on TimesSquare Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.